Bio-Tech; In More Trouble If This Fails

Since the summer of 2015, Bio-Tech has remained a leader, a “downside leader!” IBB has lagged the S&P by over 35% in the past 15-months. Is the downside leadership over for IBB?
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.